Literature DB >> 29326266

The epigenetic control of stemness in CD8+ T cell fate commitment.

Luigia Pace1,2,3, Christel Goudot4,2, Elina Zueva4,2, Paul Gueguen4,2, Nina Burgdorf4,2, Joshua J Waterfall4,5,6, Jean-Pierre Quivy4,7,8, Geneviève Almouzni4,7,8, Sebastian Amigorena4,2.   

Abstract

After priming, naïve CD8+ T lymphocytes establish specific heritable transcription programs that define progression to long-lasting memory cells or to short-lived effector cells. Although lineage specification is critical for protection, it remains unclear how chromatin dynamics contributes to the control of gene expression programs. We explored the role of gene silencing by the histone methyltransferase Suv39h1. In murine CD8+ T cells activated after Listeria monocytogenes infection, Suv39h1-dependent trimethylation of histone H3 lysine 9 controls the expression of a set of stem cell-related memory genes. Single-cell RNA sequencing revealed a defect in silencing of stem/memory genes selectively in Suv39h1-defective T cell effectors. As a result, Suv39h1-defective CD8+ T cells show sustained survival and increased long-term memory reprogramming capacity. Thus, Suv39h1 plays a critical role in marking chromatin to silence stem/memory genes during CD8+ T effector terminal differentiation.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29326266     DOI: 10.1126/science.aah6499

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  73 in total

Review 1.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

2.  Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Authors:  Lorraine Yeo; Alyssa Woodwyk; Sanjana Sood; Anna Lorenc; Martin Eichmann; Irma Pujol-Autonell; Rosella Melchiotti; Ania Skowera; Efthymios Fidanis; Garry M Dolton; Katie Tungatt; Andrew K Sewell; Susanne Heck; Alka Saxena; Craig A Beam; Mark Peakman
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

Review 3.  Epigenetics of T cell aging.

Authors:  Jörg J Goronzy; Bin Hu; Chulwoo Kim; Rohit R Jadhav; Cornelia M Weyand
Journal:  J Leukoc Biol       Date:  2018-06-27       Impact factor: 4.962

Review 4.  Role of H3K9me3 heterochromatin in cell identity establishment and maintenance.

Authors:  Dario Nicetto; Kenneth S Zaret
Journal:  Curr Opin Genet Dev       Date:  2019-05-16       Impact factor: 5.578

Review 5.  Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy.

Authors:  Caitlin C Zebley; Stephen Gottschalk; Ben Youngblood
Journal:  Trends Immunol       Date:  2020-07-02       Impact factor: 16.687

6.  SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.

Authors:  Chunwan Lu; Dafeng Yang; John D Klement; Il Kyu Oh; Natasha M Savage; Jennifer L Waller; Aaron H Colby; Mark W Grinstaff; Nicholas H Oberlies; Cedric J Pearce; Zhiliang Xie; Samuel K Kulp; Christopher C Coss; Mitch A Phelps; Thomas Albers; Iryna O Lebedyeva; Kebin Liu
Journal:  Cancer Immunol Res       Date:  2019-01-04       Impact factor: 11.151

Review 7.  Stem, Effector, and Hybrid States of Memory CD8+ T Cells.

Authors:  Enrico Lugli; Giovanni Galletti; Shannon K Boi; Benjamin A Youngblood
Journal:  Trends Immunol       Date:  2019-12-04       Impact factor: 16.687

8.  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.

Authors:  Junya Peng; Bao-Fa Sun; Chuan-Yuan Chen; Jia-Yi Zhou; Yu-Sheng Chen; Hao Chen; Lulu Liu; Dan Huang; Jialin Jiang; Guan-Shen Cui; Ying Yang; Wenze Wang; Dan Guo; Menghua Dai; Junchao Guo; Taiping Zhang; Quan Liao; Yi Liu; Yong-Liang Zhao; Da-Li Han; Yupei Zhao; Yun-Gui Yang; Wenming Wu
Journal:  Cell Res       Date:  2019-07-04       Impact factor: 25.617

9.  SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.

Authors:  Chunwan Lu; John D Klement; Dafeng Yang; Thomas Albers; Iryna O Lebedyeva; Jennifer L Waller; Kebin Liu
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

Review 10.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.